3.73
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
11.77%
1.5106
|
1.3515 | 1.5928 | 1.4461 | 1.2695 |
|
|
2.48%
4.8454
|
4.9685 | 4.7298 | 3.7389 | 3.785 |
| Depreciation and Amortization |
46.25%
0.0616
|
0.1145 | 0.1237 | 0.1134 | 0.1132 |
| Operating Income/Loss |
7.80%
-3.3349
|
-3.617 | -3.137 | -2.2928 | -2.5156 |
| Nonoperating Income/Loss |
128.97%
-0.0312
|
-0.0136 | 0.00268 | -2.7551 | -1.5162 |
| Income/Loss From Continuing Operations Before Tax |
7.29%
-3.3661
|
-3.6306 | -3.1343 | -5.0479 | -4.0318 |
| Net Income/Loss |
7.29%
-3.3661
|
-3.6306 | -3.1375 | -5.0511 | -4.0608 |
| Basic Average Shares |
16.29%
5.2268
|
4.4948 | - | 1.0664 | 24.02 |
| Diluted Average Shares |
16.29%
5.2268
|
4.4948 | - | 1.0664 | 24.02 |
| Basic Earnings Per Share |
20.99%
-0.64
|
-0.81 | - | -4.74 | -0.17 |
| Diluted Earnings Per Share |
20.99%
-0.64
|
-0.81 | - | -4.74 | -0.17 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):